THC Therapeutics Inc 最大收入来源是 Software,在最近的收益报告中收入为 7,000。就地区而言, United States 是 THC Therapeutics Inc 的主要市场,收入为 7,000。
THC Therapeutics Inc 是否盈利?
不,根据最新的财务报表,THC Therapeutics Inc 的净损失为 $0
THC Therapeutics Inc 有负债吗?
不,THC Therapeutics Inc 的负债为 0
THC Therapeutics Inc 的流通股有多少?
THC Therapeutics Inc 的总流通股为 0
关键数据
前收盘价
$0.0014
开盘价
$0.0001
当日区间
$0.0001 - $0.0014
52周范围
$0.0001 - $0.1
交易量
227.6K
平均成交量
13.5K
股息收益率
--
每股收益(TTM)
-0.02
市值
$56.3K
什么是 THCT?
THC Therapeutics, Inc. engages in developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The company is headquartered in Las Vegas, Nevada and currently employs 1 full-time employees. The company went IPO on 2007-12-07. The firm is focused on developing a sanitizing herb dryer, the dHydronator, with multiple design, function, and usage patents. The dHydronator product is specifically designed for the drying and sanitizing (i.e., reducing the bacterial count by using ultraviolet light) of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The dHydronator can reduce the moisture content of cannabis to 10-15% in only 10-14 hours. The company can also reduce the bacterial count of cannabis during the drying process. The firm also operates a portfolio of companies in genetics, cultivation, extraction, and distribution as well as specialty real estate and nutrients for commercial and hobby cannabis growers. These companies consist of Jefferson Soul, Kalix, NPK Industries, Harvest Food for Life, Shasta Properties Management, and Blue Sky Investments.